Literature DB >> 25678977

POEMS syndrome - A case report revealing a complex evolving diagnosis.

David N Gachoka1, Gregory Prince2.   

Abstract

Description of POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes) goes back to 1938 when a patient with sensorimotor peripheral neuropathy, hyperpigmemntation, solitary plasmacytoma, and elevated cerebral spinal fluid protein was reported. Since then, numerous other cases of this condition have been described by various authors including one that followed the first case 18 years later about two patients. Even though this rare condition still remains an oddity in diagnosis calling for clinicians to have a high index of suspicion due to its manifestation with varied clinical features. We present a case of POEMS syndrome that started as an episode of transient ischemic attack (TIA) and elevated levels of digestive enzymes not previously reported.

Entities:  

Keywords:  Amylase; immunoglobulin; lambda light chain; lipase; monoclonal; smudge cells

Year:  2014        PMID: 25678977      PMCID: PMC4317215          DOI: 10.1002/ccr3.148

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Case

A 98-year-old female presented to our emergency room (ER) with family after experiencing a 15-min episode of dysarthria while at home. She had been self-reliant until 4 months ago when she started to experience lower extremity weakness, mild loss of Lower extremities sensation, frequent episodes of tripping, and near fall at her house prompting her to move in with her daughter. On arrival to the ER, her speech had returned back to normal. Her medical history was only significant for a left breast mastectomy done 40 years ago due to ductal carcinoma in situ, hypothyroidism, and a well-controlled hypertension. Physical examination revealed an aged well-kempt female who was appropriate for age with good memory and mental status. Her cranial nerves were grossly intact. She had three none tender enlarged lymph nodes, each about 0.5 × 0.9 cm spread in her anterior and middle neck triangles. She also had notable mild bilateral lower extremities weakness, decreased sensation, and telangiectasia. Her home medications included levothyroxin 88 μg once daily and atenolol 25 mg once daily. Her vital signs were normal and stable. Stroke evaluation was commenced. Laboratory data results were as follows: white blood cells (WBC) 11.6 × 10/L, hemoglobin 12.1 g/dL, hematocrit 36.7%, absolute neutrophils 4 × 10/L, absolute lymphocytes 7 × 10/L, platelets 211 × 10/L, band 4%, lymphocytes 67%, smudge cell +1, amylase 116 μ/L, lipase 105 μ/L, (thyroid stimulating hormone) TSH 91.69, Free T4 < 0.25, albumin 3.3, sodium 127 mmol/L, creatinine 1.3 mg/dL, Glucose 95, lactic acid 14, troponins 0.01 ng/mL, calcium 8.8 mg/dL, alkaline phosphate 82 μ/L, (aspartate transaminase) AST 27 μ/L, and (alanine transaminase) ALT 14 μ/L. Abdominal series and chest X-ray showed large hiatal hernia, nonobstructive and nonspecific bowel gas pattern and numerous calcified granulomas throughout the lung. Computer tomographic (CT) imaging of the head without contrast showed no evidence of acute process but presence of diffuse osteopenia, patchy demineralization, or sclerotic bone lesions throughout the calvarium that could relate to age or mild dysplastic process. CT abdomen and Pelvis showed a normal gastrointestinal tract and related organs. Further analysis of complete blood count (CBC) was as follows: Peripheral smear showed absolute lymphocytosis composed of mature but mildly atypical lymphoid cells. Several smudge cells and small numbers of bands showing slight toxic granulation. Monocytes and platelets were unremarkable. Erythrocytes showed slight anisocytosis and ovalocytes (Fig1).
Figure 1

Peripheral smear.

Peripheral smear. Urine protein electrophoresis showed no evidence of monoclonal antibody. Serum protein electrophoresis showed protein tracing in (Fig2). Serum protein electrophoresis fractions showing restriction band in gamma region measuring 0.79/dL and hypoalbuminuria (Table1). Immunofixation gel scan showed IgG Lambda and faint IgM Lambda (Fig3). Free light protein fractions showed elevated free Kappa and free Lambda light chains (Table2). Lipase and amylase levels during the length of stay are as in (Fig4).
Figure 2

Protein electrophoresis.

Table 1

Serum protein electrophoresis fractions showing restriction band in gamma region

%g/dL
Fractions
 Albumin54.33.3
 Alpha 12.50.2
 Alpha 29.30.6
 Beta8.60.5
 Gamma25.31.5
Peaks
 111.20.7
Figure 3

Protein immunofixation scan.

Table 2

Free light protein fractions showing elevated lambda and kappa proteins

Protein value
NameValueRangeUnit
IgG2150694–1618mg/day
IgA337 69–378mg/day
IgM118 60–263mg/day
K free4.940.33–1.94mg/day
L free3.660.57–2.63mg/day
R K/L1.350.26–1.65mg/day
Figure 4

Digestive enzymes level during LOS.

Serum protein electrophoresis fractions showing restriction band in gamma region Free light protein fractions showing elevated lambda and kappa proteins Protein electrophoresis. Protein immunofixation scan. Digestive enzymes level during LOS.

Discussion

The etiology and incidence of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes) syndrome remains currently unknown. Several theories including overproduction of interleukins or vascular endothelial factors (VEGF) have been advanced to explain the genesis of this disease 1,2. Similarly, the incidence of this syndrome remains unknown due to complexity of the clinical manifestations that are multisystem. Dispenzieri et al., 3 have come up with the criteria for diagnosis of POEMS syndrome which include major mandatory criteria, other major criteria and minor criteria. Major mandatory criteria include polyneuropathy and monoclonal plasma proliferative disorders. Both of these findings must be present in diagnosis of POEMS. For other major and minor criteria, only one or more of each is required as an addition to the major mandatory criteria to establish diagnosis. They include for other major criteria, sclerotic bone lesions, castleman's disease, or elevated levels of vascular endothelia growth factors. Minor criteria include organomegaly, extravascular volume overload, endocrinopathy, skin changes, papilledema, and thrombocytosis or polycythemia. Our case patient fulfilled all the above criteria. On average, this syndrome presents in the fifth to sixth decade of life placing our case patient as an outlier 3. The type of light chain seen in POEMS syndrome is almost always lambda 4. This was confirmed from our immunofixation and free light protein fractionation results. Of note is that on arrival to ER, our patient was ascribed a possible diagnosis of multiple myeloma after a reading of her head CT and CBC analysis. However, after reviewing her history and laboratory results, this diagnosis was negated on the premises of the prevailing polyneuropathy found almost exclusively in POEMS syndrome and the absence of anemia, hypercalcemia, or osteolytic bone lesions found in multiple myeloma 3. The patient's urine electrophoresis was also negative for myeloma proteins. Despite this, we were absolutely aware that about 3% of patients with multiple myeloma are nonsecretors of myeloma proteins 5. Her renal function did return to normal after adequate oral hydration during her length of stay. We attributed her presenting hyponatremia to severe hypothyroidism 6 and increased her levothyroxin to 125 μg with plan for her to follow up with her primary care provider upon discharge. One finding on her laboratory results that we could not ascribe to POEMS syndrome was the elevated levels of amylase and lipase. During her entire stay, these enzymes stayed elevated with mild fluctuation. We also noted that the patient never complained of any symptoms or display any clinical manifestations as would be expected with this abnormality. She denied any history of alcohol use, pancreatitis, gall stones, or previous knowledge of this abnormality. She was even able to finish more than half of her daily meals before discharge without any abdominal pain. Her abdominal series and CT abdomen and pelvis results were also benign. After literature search, we failed to find support for previous case reports with such findings in POEMS syndrome. Due to the presence of smudge cells on the peripheral smear, we attempted to find out whether the patient had an underlying leukemia beside POEMS syndrome by doing flow cytometry. However, the patient's family requested us to terminate further testing for them to continue conservative management at home. Despite this, we can report that even though the patient had presented with cervical lymphadenopathy, she never reported more than 10% weight loss within the last 6 months, fevers, night sweats, or extreme fatigue as would be associated with some chronic lymphocytic leukemia (CLL) patients 7. Also, the pathologist was not convinced that the patient did have CLL going by the number of absolute lymphocytes in her CBC. Lastly, presentation of transient ischemic attack or development of stroke in POEMS syndrome is rare as reported in Mayo clinic series where only 9.2% of the patients, (n = 208) developed cerebral infarction at a mean age of 53 8.

Conclusion

POEMS syndrome does present with a constellation of signs and symptoms that may lead a clinician to a multitude of other possible diagnosis. A good history and physical examination as well as careful review of all workup are paramount in establishing this particular diagnosis. The finding of elevated digestive enzymes in our case patient is novel and may still be another endocrine criterion that has not yet been documented in this syndrome.

Conflict of Interest

None declared.
  8 in total

1.  Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome.

Authors:  Daijiro Abe; Chiaki Nakaseko; Masahiro Takeuchi; Hiroaki Tanaka; Chikako Ohwada; Emiko Sakaida; Yusuke Takeda; Kayo Oda; Shinichi Ozawa; Naomi Shimizu; Shinichi Masuda; Ryuko Cho; Miki Nishimura; Sonoko Misawa; Satoshi Kuwabara; Yasushi Saito
Journal:  Blood       Date:  2008-05-22       Impact factor: 22.113

2.  Hyponatraemia, hypothyroidism, and role of arginine-vasopressin.

Authors:  F W Hanna; M F Scanlon
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

3.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

4.  Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics.

Authors:  S A Dupont; A Dispenzieri; M L Mauermann; A A Rabinstein; R D Brown
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

5.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

6.  Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome.

Authors:  R K Gherardi; L Bélec; M Soubrier; D Malapert; M Zuber; J P Viard; L Intrator; J D Degos; F J Authier
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

7.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

8.  Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.

Authors:  Marina Scarlato; Stefano Carlo Previtali; Marinella Carpo; Davide Pareyson; Chiara Briani; Roberto Del Bo; Eduardo Nobile-Orazio; Angelo Quattrini; Giacomo Pietro Comi
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.